C569 Threat

For several consecutive days, Su's Group failed to provide a definitive answer. Nor did they offer a clear strategy in response. Consequently, the stock price of Su's Group continued to plummet. Meanwhile, Gusu Yan was met with a steady stream of positive news. Since the release of their family's newly developed medicine, it quickly became a favorite among many